# Omada Health Startup profile on Capital Atlas: https://capitalatlas.ai/startups/omada-health - Industry: Healthcare IT - Headquarters: San Francisco, US - Website: www.omadahealth.com - Total disclosed funding: $500M - Latest round: Series E (Feb 23, 2022) - Investors on record: 24 ## About Omada Health, Inc. is a digital health company that offers personalized virtual care programs to manage chronic conditions, featuring tailored coaching and smart health devices, promoting healthier lifestyles.Founded in 2011, Omada Health, Inc. specializes in virtual care for chronic conditions. The company, headquartered in San Francisco, US, has engaged in 11 deals, with the most recent funding round occurring on February 23, 2022. In this Series E round, Omada raised USD 192.000 mn, led by Fidelity Investments, with participation from other investors such as Civilization Ventures and Perceptive Advisors. The company was co-founded by Sean Duffy, Adrian James, and Carolyn Banach.Omada Health provides a comprehensive virtual care program designed to help individuals manage chronic health conditions such as prediabetes, diabetes, hypertension, and musculoskeletal issues. The primary offerings include personalized health coaching, smart health devices, and tailored care plans that aim to promote sustainable lifestyle changes. Omada’s program connects users with a dedicated care team, which includes health coaches and clinical specialists, who offer ongoing support and guidance on various health aspects, including nutrition, exercise, sleep, and stress management. The smart devices, which are shipped to users' homes at no cost, enable users to track key health metrics and share data with their care teams, facilitating a more integrated approach to health management. Omada’s services are primarily targeted at individuals enrolled through employers and health plans across the United States, ensuring access to a broad client base that includes both corporate partners and healthcare organizations.Omada Health employs a revenue model that largely revolves around partnerships with employers and health plans, enabling them to provide their services at no cost to eligible individuals. The company generates revenue through subscription agreements with organizations that cover the costs associated with the various health programs offered, including the flagship offerings for diabetes management, hypertension control, and joint and muscle health. These programs typically involve comprehensive packages that include personalized coaching, smart health devices, and educational content through a subscription framework. The financial structure is designed to facilitate seamless access for users while allowing organizations to promote employee health and well-being. Overall, the revenue generation strategy leverages direct partnerships with health systems and employers, focusing on delivering value through innovative digital health solutions.In February 2022, Omada Health, Inc. raised USD 192.000 mn in Series E funding, led by Fidelity Investments, to expand its workforce and enhance its technology capabilities. The company plans to introduce new products designed to further assist in managing chronic health conditions, and aims to target expansion into additional markets across the United States, with specific plans being established for deployment by 2023. ## Funding rounds - Series E, Feb 23, 2022, $192M — Wellington Management, Fidelity Investments, Perceptive Advisors, aMoon, Civilization Ventures - Series D, Mar 16, 2021, $73M — Empede Capital - Series D, May 19, 2020, $34M — Perceptive Advisors - Series D, Jun 26, 2019, $73M — US Venture Partners, Norwest Venture Partners, Cigna Investment Management, Wellington Management, Andreessen Horowitz, Kaiser Permanente Ventures, Sanofi Ventures, Allumia Ventures, Civilization Ventures - Series D, Jun 14, 2017, $50M — US Venture Partners, Norwest Venture Partners, Cigna Investment Management, Andreessen Horowitz, Humana Inc, Kaiser Permanente Ventures, Sanofi Ventures, Allumia Ventures, dRx Capital, GE Ventures - Series C, Jul 10, 2015, $49M — GE Capital, Equity, US Venture Partners, Norwest Venture Partners, Andreessen Horowitz, Humana Inc, Rock Health, Allumia Ventures, dRx Capital - Series B, Apr 4, 2014, $23M — US Venture Partners, Vertical Group, Andreessen Horowitz, Kaiser Permanente Ventures - Series A, Mar 27, 2013, $6M — New Enterprise Associates, US Venture Partners, Vertical Group, TriplePoint Capital, Kapor Capital, Founder Collective - Seed, Dec 22, 2011, $0.8M — New Enterprise Associates, Aberdare Ventures, TriplePoint Capital, Kapor Capital - Seed, May 1, 2011, $0M — Founder Collective, Rock Health ## Investors - Founder Collective (https://capitalatlas.ai/funds/founder-collective) — Seed, Series A - Rock Health (https://capitalatlas.ai/funds/rock-health) — Seed, Series C - New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Seed, Series A - Aberdare Ventures (https://capitalatlas.ai/funds/aberdare-ventures) — Seed - TriplePoint Capital (https://capitalatlas.ai/funds/triplepoint-capital) — Seed, Series A - Kapor Capital (https://capitalatlas.ai/funds/kapor-capital) — Seed, Series A - US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series A, Series B, Series C, Series D - Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series A, Series B - Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series B, Series C, Series D - Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series B, Series D - GE Capital, Equity (https://capitalatlas.ai/funds/ge-capital-equity) — Series C - Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series C, Series D - Humana Inc — Series C, Series D - Allumia Ventures (https://capitalatlas.ai/funds/allumia-ventures) — Series C, Series D - dRx Capital (https://capitalatlas.ai/funds/drx-capital) — Series C, Series D - Cigna Investment Management (https://capitalatlas.ai/funds/cigna-investment-management) — Series D - Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series D - GE Ventures — Series D - Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series D, Series E - Civilization Ventures (https://capitalatlas.ai/funds/civilization-ventures) — Series D, Series E - Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series D, Series E - Empede Capital (https://capitalatlas.ai/funds/empede-capital) — Series D - Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series E - aMoon (https://capitalatlas.ai/funds/amoon) — Series E